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The kidney of the Gpc32/ mouse, a novel model of human renal dysplasia, is characterized by selective degeneration of
medullary collecting ducts preceded by enhanced cell proliferation and overgrowth during branching morphogenesis. Here,
we identify cellular and molecular mechanisms underlying this renal dysplasia. Glypican-3 (GPC3) deficiency was
associated with abnormal and contrasting rates of proliferation and apoptosis in cortical (CCD) and medullary collecting
duct (MCD) cells. In CCD, cell proliferation was increased threefold. In MCD, apoptosis was increased 16-fold. Expression
of Gpc3 mRNA in ureteric bud and collecting duct cells suggested that GPC3 can exert direct effects in these cells. Indeed,
GPC3 deficiency abrogated the inhibitory activity of BMP2 on branch formation in embryonic kidney explants, converted
BMP7-dependent inhibition to stimulation, and enhanced the stimulatory effects of KGF. Similar comparative differences
were found in collecting duct cell lines derived from GPC3-deficient and wild type mice and induced to form tubular
progenitors in vitro, suggesting that GPC3 directly controls collecting duct cell responses. We propose that GPC3 modulates
the actions of stimulatory and inhibitory growth factors during branching morphogenesis. © 2001 Academic Press














Glypicans, defined as glycosyl phosphotidyl inositol
(GPI)-linked heparan sulfate proteoglycans (HSPG), play
essential roles during embryogenesis. This was first dem-
onstrated via the analysis of flies harboring a mutation in
dally, a glypican-like gene in Drosophila (Nakato et al.,
1995). This was followed by the recognition that the gene
encoding glypican-3 (Gpc3) is mutated in a subset of indi-
viduals with Simpson–Golabi–Behmel Syndrome (SGBS).
SGBS is an X-linked disorder characterized by pre- and
postnatal overgrowth, renal medullary cystic dysplasia, and
other malformations including skeletal anomolies and an
increased risk of developing embryonal tumors (Neri et al.,
1998; Pilia et al., 1996). More recently, analysis of two
independently generated mouse Gpc3 knock-out models
(Cano-Gauci et al., 1999; Paine-Saunders et al., 2000) has
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mammals to regulate morphogenesis, and has demon-
strated a genetic interaction between GPC3 and BMP4
during limb and skeletal development (Paine-Saunders et
al., 2000).
Medullary renal dysplasia is a major anomaly in Gpc3
knock-out mice (Cano-Gauci et al., 1999). Analysis of the
mbryologic basis for this dysplasia demonstrated a poten-
ially novel mechanism underlying the degeneration of the
idney medulla starting at the midpoint of kidney develop-
ent in utero. While previously described experimental
odels of renal dysplasia are caused by interruption of
nductive pathways that act during the initial stages of
idney development, in the Gpc32/ kidney, induction of
reteric bud branching and metanephric epithelialization
ppears to be normal. However, overgrowth of the ureteric
ud, but not the blastema-derived tissue elements, can be
emonstrated as early as 1 day after induction of the
lastema. This selective ureteric bud overgrowth is accom-
anied by a threefold increase in ureteric bud cell and
ollecting duct cell proliferation, starting as early as E12











































32 Grisaru et al.Thus, in the embryonic kidney, GPC3 is required for
normal development of the ureteric bud and its collecting
duct derivatives.
The morphogenesis of structures in the ureteric bud cell
lineage, a process termed branching morphogenesis, is
controlled by peptide growth factors including members of
the bone morphogenetic protein (BMP) and fibroblast
growth factor (FGF) families (reviewed in Pohl et al., 2000).
Members of the BMP and FGF families generate stimula-
tory and inhibitory activities that are integrated by ureteric
bud and collecting duct cells to regulate tubule growth and
branching. BMP2 is expressed in metanephric mesenchy-
mal cells adjacent to ureteric bud branches and collecting
ducts. Early embryonic lethality in BMP2 knock-out mice
(Zhang and Bradley, 1996) has precluded the study of BMP2
functions during renal development; however, treatment of
embryonic kidney explants with BMP2 inhibits branching
morphogenesis (Piscione et al., 1997, 2001). BMP7 is highly
expressed not only in the ureteric bud and its branches but
also in mesenchymal cells induced by the advancing tips of
the ureteric bud and collecting ducts. Mutational inactiva-
tion of murine BMP7 causes renal dysplasia resulting from
an arrest of renal development after induction of the meta-
nephric blastema by the ureteric bud (Luo et al., 1995;
udley et al., 1995).
Further insight into the role of BMP7 has been provided
y the demonstration that BMP7 exerts dose-dependent and
pposite effects on ureteric bud and collecting duct mor-
hogenesis in embryonic kidney explants and in an in vitro
odel of collecting duct morphogenesis (Piscione et al.,
997, 2001). At low doses (,0.5 nM) BMP7 stimulates
ubule number, length, and branching via a Smad1-
ndependent mechanism; at higher doses, BMP7 generates
horter, unbranched tubules in a Smad1-dependent manner
Piscione et al., 2001). A functional role for keratinocyte
rowth factor (KGF, also termed FGF7), a member of the
GF family, has also been demonstrated in knock-out mice
Qiao et al., 1999). KGF is expressed in stromal cells
djacent to the truncal portions of ureteric bud and collect-
ng duct branches (Finch et al., 1995; Qiao et al., 1999).
utational inactivation of murine KGF results in decreased
rowth of the ureteric bud and collecting ducts, while
xogenous administration of FGF7 augments ureteric bud
rowth (Qiao et al., 1999). Thus, BMP family members and
GF exert contrasting and critically important effects dur-
ng renal branching morphogenesis.
In this work, we investigated cellular and molecular
echanisms that underly the medullary dysplastic pheno-
ype in the Gpc32/ mouse. First, we compared cell prolif-
ration and survival in the developing kidney of wild type
nd Gpc32/ mice. Whereas cell proliferation is higher in
he cortical collecting duct of Gpc3-null mice, in the
edulla cell proliferation is threefold lower and apoptosis is
ncreased 16-fold. Next, we tried to define the molecular
asis of GPC3 involvement in the control of cell prolifera-
ion and apoptosis during renal development. In particular,
e tried to establish whether GPC3 could modulate the
Copyright © 2001 by Academic Press. All rightesponse to BMP2, BMP7, and KGF during branching mor-
hogenesis. Indeed, we show here that Gpc3 expression
odulates BMP and KGF effects in embryonic kidney
xplants.
MATERIALS AND METHODS
Generation of Mice and Genotyping
Gpc31/2 females (C57BL/6) were crossed with C57/BL6 wild
type males. Pups and embryos were genotyped using PCR, as
previously described (Cano-Gauci et al., 1999). Collecting duct cell
lines were genotyped using RT-PCR and the same primers used to
type genomic DNA.
In Situ Hybridization
Sense and antisense digoxigenin-11-dUTP-labeled RNA probes
were prepared according to manufacturer’s specification (RNA
labeling kit; Boehringer Mannheim, Indianapolis, IN). Ret cDNA
as kindly provided by Dr. F. Costantini, Columbia University.
nt11 and Wnt7b cDNAs were a kind gift of Dr. A. McMahon,
Harvard University. Eight- to 10-mm-thick kidney tissue cryosec-
tions were postfixed in 4% paraformaldehyde for 30 min, perme-
abilized with 40 mg/ml Proteinase-K for 10 min at room tempera-
ure, and then incubated in 0.1 M triethanolamine (pH 8.0)/0.25%
cetic anhydride for 10 min at room temperature. Slides were then
ashed in PBS and prehybridized in hybridization buffer (50%
ormamide, 53 SSC, 53 Denhardt’s solution, 0.5 mg/ml yeast
tRNA) for 3 h at 60°C, after which 15–25 ml of probe was added and
hybridization was continued at 55°C overnight. Washes were
performed as follows: 15 min in 53 SSC at 55°C, 60 min in 0.23
SSC at 60°C, 10 min in RNase buffer (0.4 M NaCl, 10 mM
Tris–HCl, pH 7.5, 5 mM EDTA) at 37°C, 30 min in 0.02 mg/ml
RNase A in RNase buffer at 37°C, 5 min in RNase buffer at 37°C,
10 min in 23 SSC at 37°C, and 10 min in 0.23 SSC at 37°C. Signal
detection was performed according to manufacturer’s specification
(Nucleic acid detection kit; Boehringer Mannheim).
Cell Proliferation and Apoptosis
Ureteric bud and collecting duct cell proliferation was detected
in embryonic kidneys using an in situ 5 bromo-29deoxyuridine
(BrdU) incorporation assay, as previously described (Cano-Gauci et
al., 1999). Apoptotic cells were detected using in situ TUNEL
abeling, as previously described (Gupta et al., 1999), with the
following minor modifications. Following rehydration, slides were
first boiled for 10 min in a microwave Crock-Pot immersed in
citrate buffer (pH 6.0) and then treated for 5–10 min with 2 mg/ml
Proteinase-K at room temperature. In situ BrdU detection and
TUNEL labeling were performed in cultured collecting duct cells
using commercially available kits (Boehringer Mannheim).
Embryonic Kidney Organ Culture
E12.5 kidneys were cultured and treated with BMP2, BMP7, or
KGF absorbed onto Affi-Gel blue agarose beads and manually
placed on the peripheral cortex of one side of the kidney, as
previously described (Piscione et al., 2001). After 48 h of culture in
serum-free medium, the kidneys were fixed with 4% formaldehyde
















33Glypican-3 Controls Renal Branching Morphogenesisin PBS and incubated overnight with 20 ng/L Dolichos Biflorus
Agglutinin (DBA). The ureteric bud branches were imaged by
fluorescence microscopy. The effect on branching morphogenesis
was evaluated by counting the number of branch points, defined as
the intersection between two connected branches, on each side of
the ureteric bud.
Isolation of Gpc31/ and Gpc32/ Collecting Duct
Cells
Collecting duct cell lines were isolated from Gpc31/ and
Gpc32/ E18.5 mouse embryos as previously described (Wang et al.,
1999), with the following modifications. A male homozygote
Immortomouse (Charles River, Portage, MI) transgenic for the
SV40 large T antigen was mated with a Gpc32/ or Gpc31/ female.
Kidneys were isolated from F1 embryos at E18.5 and placed in
DMEM/F12 with 10% fetal bovine serum (FBS; Life Technologies,
Gaithersburg, MD) overnight. After establishing the genotype of
each embryo from which the kidneys were isolated, the renal
papilla was isolated by microdissection in phosphate-buffered
saline, pH 7.4. The papillae were minced and incubated in DMEM/
F12 with 1% FBS and 200 mg/ml type I collagenase (Life Technolo-
gies). Next, cells were pelleted and cultured in 96-well tissue
culture plates in DMEM/F12 with 5% FBS containing 50 IU/ml
g-interferon. Cells were expanded, analyzed for DBA binding, and
then cloned by limiting dilution.
In Vitro Tubulogenesis Assay
Collecting duct cells were suspended in a type I collagen three-
dimensional matrix and induced to form tubules in the presence of
DMEM/F12/5% FBS as previously described (Piscione et al., 1997).
The effect of BMP2, BMP7, or KGF on tubule formation was
determined by adding ligand to the culture medium at the initia-
tion of the culture. After 48 h the gels were fixed in 4% formalde-
hyde and imaged by differential interference contrast (DIC) micros-
copy using a Zeiss Axioskop microscope (Zeiss, Thornwood, NY).
The number of tubules formed in each gel was determined by
counting the number of linear structures in four randomly chosen
microscopic fields (Piscione et al., 2001). The identity of each
treatment group was unknown to the observer at the time of
analysis.
Statistical Analysis
Data were analyzed using the StatView statistical analysis
program (version 4.01; Abacus Concepts, Berkeley, CA). Mean
differences were examined by Student’s two-tailed t test. Signifi-
cance was taken at a value of P , 0.05 (two-tailed).
RESULTS
Cell Proliferation and Apoptosis Are Differentially
Regulated in the Renal Cortex and Medulla of the
Gpc32/ Mouse
In our previous work, we characterized the kidney phe-
notype in the Gpc32/ mouse and determined that ureteric
bud and collecting duct cell but not mesenchymal cell
proliferation is elevated threefold above that in wild type
Copyright © 2001 by Academic Press. All rightidneys at E12.5, E13.5, and E16.5 (Cano-Gauci et al., 1999).
lthough these observations explained the ureteric bud and
ollecting duct overgrowth, they do not explain the selec-
ive degeneration of tissue elements in the renal medulla.
herefore, we compared the rates of proliferation and apo-
tosis in the renal cortex and medulla at E16.5, the time
oint at which the medullary degeneration can be detected
Fig. 1). Pregnant Gpc31/2 female mice were injected with
BrdU 4 h before embryos were isolated at E16.5. BrdU
incorporation into collecting duct cells was analyzed using
an in situ BrdU incorporation assay. The renal cortex is
defined as that area of tissue containing glomeruli, and the
medulla is defined as that portion of the kidney located
between the cortex and the renal pelvis. Qualitative analy-
sis of sagittal tissue sections (Figs. 1A and 1B) suggested
that BrdU incorporation was increased in the cortex but not
the medulla of kidneys of Gpc32/ mice. Higher-power
imaging of collecting duct structures (Figs. 1C and 1D)
demonstrated higher BrdU incorporation in the epithelial
component of Gpc32/ mice. Consistent with our previous
report, BrdU incorporation into mesenchymal cells sur-
rounding collecting ducts did not differ between Gpc31/
and Gpc32/ mice. Quantitation of BrdU incorporation (Fig.
3A) demonstrated a 3.1-fold increase in cortical collecting
duct cell proliferation in Gpc32/ compared to that in
Gpc31/ kidneys (P 5 0.01). In contrast, cell proliferation in
medullary collecting ducts did not differ significantly be-
tween Gpc31/ and Gpc32/ mice (P 5 0.08), although there
was a tendency toward a lower rate of cell proliferation in
medullary collecting ducts of Gpc32/ kidneys.
Apoptosis was analyzed using an in situ TUNEL assay in
E16.5 kidney tissue sections generated from the same
kidneys analyzed for BrdU incorporation. Consistent with a
previous report (Koseki et al., 1992), apoptosis was re-
tricted to the outermost mesenchymal cells in the cortex
t E16.5 in the wild type kidney. In contrast, a high degree
f TUNEL-positivity was evident in the medulla of the
pc32/ kidney (Figs. 2A and 2B). Quantitation of apoptosis
Fig. 3B) revealed that apoptosis was not increased signifi-
antly until E16.5, at which time apoptosis was increased
6-fold in the Gpc32/ kidney (P . 0.0001). Analysis of
higher-resolution images of collecting ducts (Figs. 2C–2F)
demonstrated that apoptosis was predominant in the med-
ullary collecting duct compared to the cortical component
of the collecting duct in the Gpc32/ kidney. These obser-
vations suggest that the selective degeneration of the med-
ullary collecting duct is the result of massive apoptosis in
these structures.
Medullary cysts, defined as epithelial structures with a
diameter 2.5-fold greater than normal tubules, are a promi-
nent feature of the renal phenotype in the Gpc32/ mouse
and a characteristic finding in human renal dysplasia (Bern-
stein, 1971). Yet, the origin of cyst cells and the cell biology
of cyst formation in the dysplastic kidney is only beginning
to be defined (Winyard et al., 1996a). DBA staining of the
Gpc32/ kidney demonstrated positive staining of the vast
majority of cysts and suggested that cyst cells are derived
s of reproduction in any form reserved.
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34 Grisaru et al.FIG. 1. GPC3 differentially regulates cell proliferation in cortical and medullary collecting ducts. Cell proliferation was analyzed in
paraffin-embedded E16.5 kidney sections using an in situ BrdU incorporation assay. Ureteric bud branches and collecting ducts were
dentified with DBA: (A, B) Bright-field images of E16.5 wild type and mutant kidneys stained with anti-BrdU antibody. Cell proliferation,
ndicated by brown-colored cells, is prominent in the kidney cortex and is increased in the Gpc32/ kidney. (C, D) Bright-field images of
representative branched collecting ducts present in kidneys displayed in (A) and (B), respectively. The number of BrdU-positive
(brown-colored) cells is increased in collecting ducts from Gpc32/ mice. (E, F) Fluorescence images corresponding to tissue imaged in (E)
and (F). The positive staining with DBA indicates that the structures are ureteric bud branches or collecting ducts. (G, H) Bright-field (G)
and fluorescence (H) images of epithelial cysts present in the medulla of the E16.5 Gpc32/ kidney. The cysts are lined by either cuboidal
cells that strongly react with DBA or squamous-appearing cells that react weakly with DBA. BrdU-positive cells are present in both types
of cysts. Magnification: (A, B) 3100; (C–H) 3400.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
35Glypican-3 Controls Renal Branching MorphogenesisFIG. 2. Medullary collecting ducts undergo apoptosis in the Gpc32/ kidney. Apoptosis was analyzed in paraffin-embedded E16.5 kidney
sections using an in situ TUNEL assay. Ureteric bud branches and collecting ducts were identified with DBA. (A) Apoptosis is rarely
observed in the E16.5 wild type kidney. TUNEL-positive (brown-colored) cells are present at the outermost rim of the cortex in
mesenchymal cells not induced to form epithelial elements. (B) In the Gpc32/ kidney, tubules lined almost totally with brown-colored cells
are present in the medulla but to a far lesser extent in the cortex. (C, D) Higher magnification image of tissue region containing collecting
ducts in wild type (C) and GPC3-deficient kidney (D). The same structures, stained with DBA, are shown in (E) and (F). No TUNEL-positive
cells are observed in the wild type kidney. In contrast, the medullary portion of the Gpc32/ collecting duct contains a large number of
TUNEL-positive cells. (G, H) Apoptosis in DBA-positive cystic structures in the Gpc32/ kidney medulla. A large number of
TUNEL-positive cells are present. Magnification: (A, B) 3100; (C, E, G, H) 3400; (D, F) 3800.
















36 Grisaru et al.from ureteric bud cells (Figs. 1G, 1H, 2G, 2H). Two classes
of cysts were recognized: (1) cysts composed of cuboidal
cells that were strongly identified by DBA and (2) cysts
containing squamous cells that were stained weakly by
DBA. The rate of cell proliferation in both classes of cysts
was significantly elevated compared to that in noncystic
collecting ducts (cell proliferation: cuboidal cell cysts, 4.9-
fold higher, P 5 0.002 and squamous cell cysts, 3.2-fold
FIG. 3. Quantitation of collecting duct and cyst cell proliferatio
BrdU-positive and TUNEL-positive ureteric bud branch or collecti
and 3) and expressed as percentage proliferation or apoptosis. (A) C
The histogram demonstrates a 3.1-fold higher proliferation rate in
roliferation: 15.6 6 4.0 vs 5.0 6 2.4, P 5 0.01). In contrast, there is
(% proliferation, Gpc32/ vs Gpc31/: 5.7 6 1.9 vs 7.7 6 1.6, P 5 0.0
f GPC3. The histogram demonstrates a 16-fold increase in apopto
pc31/ kidneys (% apoptosis, Gpc32/ vs Gpc31/: 81.7 6 15.1 v
ncreased. The number of BrdU-positive cells in DBA-positive (1
ollecting ducts in Gpc32/ kidneys. The histogram demonstrate
ncreased 4.9- and 3.2-fold, respectively, compared to that in medul
.2 6 0.5 vs 20.7 6 1.0, P 5 0.002; noncystic vs DBA-equivocal cys
is increased. The number of TUNEL-positive cells in DBA-positive
ducts in Gpc32/ kidneys. The histogram demonstrates that apop
medullary collecting ducts (% apoptosis: 89.8 6 10.9 vs 57.2 6 18
that in DBA-positive cysts (% apoptosis: 46.2 6 25.7 vs 89.8 6 10.9,
N 5 5 kidneys in each group, *P , 0.05.higher, P 5 0.02, compared to that in adjacent noncystic c
Copyright © 2001 by Academic Press. All rightollecting ducts) (Fig. 3C). Thus, elevated cell proliferation
ay contribute to cyst size in the dysplastic kidney. Inter-
stingly, increased cell proliferation in cysts was also ac-
ompanied by a high rate of apoptosis (Figs. 2G and 2H). In
uboidal cell cysts, the rate of apoptosis was even further
levated above that observed in noncystic collecting ducts
1.6-fold increase, P 5 0.0003) (Fig. 3D). Taken together,
hese results are consistent with the prior observation that
d apoptosis in the Gpc31/ and Gpc32/ kidney. The fraction of
ct cells was measured in images of E16.5 kidney sections (Figs. 2
al collecting duct proliferation is increased in the Gpc32/ kidney.
cortical collecting ducts of Gpc32/ than in Gpc31/ kidneys (%
ignificant difference in medullary collecting duct cell proliferation
) Medullary collecting duct cells undergo apoptosis in the absence
te in the collecting ducts of Gpc32/ kidneys compared to that in
6 1.7, P . 0.0001). (C) Cell proliferation in medullary cysts is
DBA-equivocal (1/2) cysts was compared to that in medullary
t cell proliferation in DBA-positive and DBA-equivocal cysts is
collecting ducts (% proliferation, noncystic vs DBA-positive cysts:
.2 6 0.5 vs 13.6 6 1.2, P 5 0.02). (D) Apoptosis in medullary cysts
BA-equivocal cysts was compared to that in medullary collecting
in DBA-positive cysts is increased 1.6-fold compared to that in
0.0003). Apoptosis in DBA-equivocal cysts is 1.9-fold lower than
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37Glypican-3 Controls Renal Branching Morphogenesiscysts of dysplastic and polycystic kidneys (Winyard et al.,
996b; Lanoix et al., 1996).
Gpc3 mRNA Is Expressed in Both Ureteric Bud
and Mesenchymal-Derived Cells in the Embryonic
Kidney
Previous studies demonstrated that GPC3 is able to bind
FGF-2 on the surface of cells (Song et al., 1997) and it has
een proposed that glypicans can act as coreceptors for
eparin-binding growth factors like FGFs (reviewed in Bern-
eld et al., 1999). However, a previous report indicated that
pc3 mRNA is expressed only in the mesenchymal cells in
he blastemal derivatives of the mouse embryonic kidney
Pellegrini et al., 1998). This would suggest that the regu-
atory activity of GPC3 in developing collecting ducts is
ndirect. To further test the possibility that Gpc3 could act
irectly, we examined the spatial and temporal pattern
xpression of Gpc3 mRNA in the embryonic kidney (Fig. 4).
n situ hybridization using a DIG-labeled probe demon-
trated marked expression in both ureteric bud and mesen-
hymal cells as early as E13.5 (Figs. 4A and 4B). Expression
t E16.5 (Figs. 4C and 4D) appeared to be similar to that at
13.5 but decreased by E18.5 (Figs. 4E and 4F). The speci-
city of Gpc3 mRNA detection was indicated by the
bsence of signal using a sense Gpc3 probe (data not shown)
r after hybridization of Gpc32/ tissue with the antisense
robe (Figs. 4G and 4H). Thus, our data indicate that Gpc3
s expressed in those cells that are targeted by GPC3
eficiency.
Ureteric Bud Branches and Collecting Ducts
Express Markers of Differentiation Normally in
Gpc32/ Mice
During renal branching morphogenesis the ureteric bud
differentiates into the cortical and medullary collecting
ducts. During this process, discrete molecular markers (Ret,
nt11) are expressed by cells at the tips of the ureteric bud
nd collecting ducts and by cells in the trunks of these
tructures (Wnt7b). Appropriate expression of these mark-
rs is a measure of differentiation. Our demonstration of
bnormal collecting duct morphogenesis in the Gpc32/
mouse suggested the possibility that GPC3 controls ure-
teric bud cell differentiation. Absence of Gpc3 expression
could interfere with the generation of collecting ducts from
the ureteric bud, resulting in the degeneration of collecting
duct cells. We tested this possibility by assessing the
expression of ureteric bud and collecting duct differentia-
tion markers in the Gpc32/ kidney (Fig. 5). In situ hybrid-
ization of E14.5 kidney tissue isolated from Gpc31/ and
Gpc32/ mice demonstrated normal expression of Ret and
Wnt11 at the tips of collecting ducts located at the periph-
eral cortex and of Wnt7b in the truncal domains located in
the interior of the kidney. These data suggest that collect-
ing duct differentiation occurs normally in the absence of
GPC3. K
Copyright © 2001 by Academic Press. All rightGPC3 Modulates the Effects of BMP2, BMP7, and
KGF on Renal Branching Morphogenesis
In the kidney, branching morphogenesis is controlled by
cell–cell interactions mediated by secreted peptide growth
factors (reviewed in Pohl et al., 2000). To date, evidence
suggests that signals from stimulatory and inhibitory path-
ways are integrated by ureteric bud and collecting duct cells
with the effect of regulating tubular number and size and
branching. Members of the BMP and FGF families regulate
these pathways. BMP2 and high doses of BMP7 are inhibitory
(Piscione et al., 1997, 2001), while KGF (Qiao et al., 1999) and
low doses of BMP7 (Piscione et al., 1997, 2001) are stimula-
tory. Data obtained from genetic crosses between BMP and
glypican mutant flies (Jackson et al., 1997) and mammals
(Paine-Saunders et al., 2000) and from cell culture experi-
ments (Bonneh-Barkay et al., 1997) suggest that glypican can
regulate BMP and KGF activity. Therefore, we decided to
investigate whether GPC3 can regulate BMP and KGF activity
during renal development. We investigated these interactions
in E12.5 embryonic kidney explants isolated from Gpc31/
and Gpc32/ mice and treated with agarose beads saturated
with BMP2, BMP7, or KGF (Piscione et al., 2001). After 48 h
of treatment in culture the explant was stained with DBA
to selectively mark the position of the ureteric bud and its
branches (Fig. 6). The effect on branching morphogenesis
was determined by comparing the number of ureteric bud
branch points on the side of the bead to that on the
untreated side of the explant (Piscione et al., 1997). Since
the number of branch points on one side of the ureter is at
least 95% of that on the other side (Piscione et al., 1997), a
larger difference in the number of branch points should
reflect a true effect of treatment.
Consistent with our previous results (Piscione et al., 1997),
MP2 decreased branch formation in Gpc31/ kidney ex-
lants. In Gpc32/ explants, no inhibitory effect was observed
Fig. 6). Quantitation of these BMP2-mediated effects (Fig. 7)
emonstrated that deficiency of GPC3 abrogated the inhibi-
ory effect 10-fold (P 5 0.003). BMP7 exerted a less potent but
lear inhibitory effect in the tissue surrounding the bead in the
pc31/ explant, consistent with its known inhibitory effects
t high doses (Piscione et al., 1997). In contrast, in Gpc32/
xplants, no inhibitory effect was observed. In fact, BMP7
timulated branching in these mice. Quantitation of these
ffects (Fig. 7) showed that, whereas BMP7 inhibited branch
oint formation by 27% in Gpc31/ explants, it stimulated
ranch point formation by 14% in Gpc32/ explants. KGF
timulated branch point formation in both Gpc31/ and
pc32/ kidneys (Fig. 6). Quantitation of the effect (Fig. 7)
emonstrated that the stimulatory effect was fourfold greater
n explants isolated from Gpc32/ mice. These results are
onsistent with the observation that glypican strongly inhib-
ts the mitogenic response to KGF in keratinocytes (Bonneh-
arkay et al., 1997). Taken together, our results suggest that
PC3 normally acts to promote signaling via the BMP inhibi-
ory pathway and to antagonize signaling via the BMP- and
GF-mediated stimulatory pathways. In the Gpc32/ embry-





38 Grisaru et al.FIG. 4. Gpc3 mRNA is expressed in mesenchymal and epithelial-derived tissue elements during renal development. In situ hybridization
sing a DIG-labeled antisense Gpc3 RNA probe in frozen embryonic kidney tissue sections isolated from Gpc31/ (A–F) and Gpc32/ (G, H)
ice. Gpc3 mRNA is strongly expressed as early as E13.5 in both mesenchyme-derived tissue (arrowhead) and in the ureteric bud (arrow)
A, B). Expression is similarly strong at E16.5 (C, D) but is decreased at E18.5 (E, F). No specific DIG signal is observed in kidney tissue
solated from E16.5 Gpc32/ mice (G, H). Magnification: (A, F) 3100; (B, D, H) 3400; (C, G) 350; (E) 325.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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39Glypican-3 Controls Renal Branching Morphogenesisonic kidney, absence of GPC3 is thus predicted to create an
imbalance of inhibitory and stimulatory signaling in favor of
stimulation and overgrowth of structures derived from the
ureteric bud.
Collecting Duct Cells Isolated from Gpc32/Kidneys
Are Characterized by Increased Rates of Proliferation
Identification of the primary role of collecting duct cells
FIG. 5. Ret, Wnt11, and Wnt7b mRNAs are expressed normally i
using DIG-labeled antisense RNA probes in frozen embryonic kidn
, F) mice. Ret mRNA (A, B) and Wnt11 mRNA (C, D) are express
oth Gpc32/ and Gpc31/ mice. (E, F) Wnt7b is expressed in the tin generating the dysplastic phenotype in the Gpc32/
Copyright © 2001 by Academic Press. All rightmouse is limited by the cellular complexity of the embry-
onic kidney and the critical role of reciprocal interactions in
controlling branching morphogenesis. To address the im-
pact of GPC3 deficiency on collecting duct cells, specifi-
cally, we generated immortalized collecting duct cell lines
by crossing Gpc32/ and Gpc31/ mice to mice transgenic
for the large T antigen (Immortamouse). Embryos were
isolated at E18.5 and collecting duct cells were isolated by
microdissection of the renal papilla. Cells derived from
embryonic kidney of GPC3-deficient mice. In situ hybridization
ssue sections isolated from E14.5 Gpc31/ (A, C, E) and Gpc32/ (B,
the tips of branching collecting ducts in the peripheral cortex in
s of collecting ducts in both Gpc31/ and Gpc32/ mice.n the
ey ti
ed inGpc31/, SV40-large Tts and Gpc32/, SV40-large Tts mice
s of reproduction in any form reserved.
40 Grisaru et al.were passaged and then cloned by limiting dilution. The
identity of these cells as derived from the ureteric bud
lineage was confirmed by staining with DBA (Fig. 8). The
genotype of each cell line was determined by identification
FIG. 6. GPC3 modulates growth factor-mediated control of renal b
on formation of branch points in E12.5 embryonic Gpc31/ and Gpc
agarose beads. The ureteric bud and its branches were selective
microscopy. Each Gpc32/ explant was larger than each Gpc31/ e
difference in size is masked in KGF-treated kidneys as a result of
spatially restricted areas of the explant can be discerned by dividi
comparing the formation of branches on each side. BMP2: In the G
of the BMP2-saturated agarose bead compared to that on the untreat
In the Gpc31/ kidney, BMP7 inhibits branch point formation in the
does BMP2. In Gpc32/ kidney, BMP7 stimulates branch point form
branch point formation in the Gpc31/ kidney. This stimulatory e
3100; KGF: 350.of Neo and Gpc3 mRNAs by RT-PCR (data not shown).
Copyright © 2001 by Academic Press. All rightWe determined whether absence of GPC3 causes pertur-
bations in the cell cycle of cells derived from the ureteric
bud, as observed in the intact kidney (Figs. 1 and 2). Cells
were labeled with BrdU under basal culture conditions and
hing morphogenesis. Qualitative effects of BMP2, BMP7, and KGF
kidney explants cultured in vitro and treated with ligand-saturated
ained with DBA and the explants were imaged by fluorescence
nt at the time cultures were initiated. After 48 h of culture, the
imulatory effect on tissue growth. The effect of ligand applied to
e explant into two, based on the position of the ureteric bud and
/ kidney, BMP2 decreases the number of branch points on the side
de. In the Gpc32/ kidney, BMP2 exerts no inhibitory effect. BMP7:
on around the BMP7-saturated agarose bead, but less potently than
in the treated vs untreated portion of tissue. KGF: KGF stimulates










ffectBrdU-positive cells were identified using an in situ BrdU













effect into a stimulatory effect. (C) KGF stimulates branch point g
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Copyright © 2001 by Academic Press. All rightincorporation assay (Figs. 8C and 8D). Comparison of
Gpc31/ and Gpc32/ cells clearly indicated that prolifera-
tion was increased in those with a Gpc32/ genotype.
Quantitation of the rate of proliferation demonstrated a
fivefold increase in Gpc32/ cells compared to that in
Gpc31/ cells (P 5 0.0003). These results were equivalent in
cells before the establishment of clones (polyclonal cells)
and in three different clonal lines.
GPC3 Modulates the Actions of BMPs and KGF
during Tubulogenesis in Vitro
Generation of cell lines derived from the collecting duct
of Gpc31/, SV40-large Tts and Gpc32/, SV40-large Tts mice
provided a basis to test whether Gpc3 acts to modulate the
effects of BMPs and KGF on branching morphogenesis via
direct actions in collecting duct cells. Formation of pretu-
bular structures was induced in three-dimensional cultures
of Gpc31/ and Gpc32/ cells. The effect of BMP2, BMP7,
and KGF on the number of tubular structures formed was
determined by imaging after 48 h in culture. The qualitative
and quantitative effects of these ligands on tubule forma-
tion in the Gpc31/ and Gpc32/ backgrounds is shown in
ig. 9 and Fig. 10, respectively. Both Gpc31/ and Gpc32/
ere able to form tubular structures under basal conditions
Fig. 9). BMP2 exerted a strong inhibitory effect on Gpc31/
ells but a much weaker effect on Gpc32/ cells. Dose–
esponse analysis demonstrated an abrogation of BMP2-
ediated inhibition in Gpc32/ cells at doses $ 0.15 nM
(Fig. 10A). An identical analysis in the presence of 0.025–25
nM BMP7 demonstrated a marked effect of Gpc3 on BMP7
action (Figs. 9 and 10B). Consistent with our prior results
(Piscione et al., 1997, 2001), BMP7 exerted dose-dependent
stimulatory and inhibitory effects in cultures of Gpc31/
cells. In contrast, in cultures of Gpc32/ cells, not only was
the stimulatory response more marked but it was also
maintained at doses which inhibit in wild type cells. That
is, the maximum degree of BMP7-mediated inhibition was
2.7-fold lower in Gpc32/ cells (25 nM BMP7, % inhibition,
Gpc31/ vs Gpc32/: 72.5 6 6.8 vs 26.2 6 5.8, P 5 0.0025).
These data suggest that GPC3 is required in the BMP
inhibitory pathway. Exaggeration of a stimulatory ligand-
dependent effect was observed in the presence of KGF (Figs.
9 and 10C). KGF stimulated tubule formation by Gpc31/
cells in a dose-dependent manner. This effect was signifi-
cantly increased at doses $ 50 ng/ml (P # 0.02). These
experiments were performed using polyclonal and two
other clonal cell lines with similar results. Taken together,
these results strongly suggest that Gpc3 expression in
formation by 14.5 6 6.9% in Gpc31/ kidneys (P 5 0.002). In the
Gpc32/ background, KGF-mediated stimulation is significantly
increased (60.6 6 28%, P 5 0.02). Minimum of six explants in eachFIG. 7. Quantification of the effect of GPC3 deficiency on growth
actor-mediated control of ureteric bud branching in cultured
mbryonic kidney explants. The number of branch points on the
ide of the ligand-saturated agarose bead was compared to that in
he untreated side and expressed as the percentage difference. In
ontrol explants, albumin-saturated agarose beads do not exert a
ignificant effect on branching in either Gpc31/ or Gpc32/ kid-
neys. (A) BMP2 decreases branch point formation by 30.1 6 2.9% in
Gpc31/ kidneys (P 5 0.0002) but only by 3.6 6 1.0% in Gpc32/
explants, representing a 10-fold rescue of inhibition in Gpc32/
compared to Gpc31/ kidneys (P 5 0.003). (B) BMP7 decreases
branch point formation by 27 6 6.0% in Gpc31/ kidneys (P 5
0.001). In Gpc32/ kidneys BMP7 stimulates branch point forma-
tion by 14 6 9.0% (P 5 0.001), thus converting the BMP7 inhibitoryroup, *P , 0.05.































42 Grisaru et al.collecting duct cells modulates the morphogenetic response
of these cells to BMP2, BMP7, and KGF, as demonstrated in
embryonic kidney explants.
DISCUSSION
A general requirement for heparan sulfate during embryo-
genesis has been demonstrated via analysis of the phenotype
of fly and mouse mutants for genes that encode enzymes in
the heparan sulfate synthesis pathway. Sugarless (sgl) and
ulfateless (sfl) are fly homologs of bovine UDP-glucose dehy-
rogenase and mammalian N-deacetylase/N-sulfotransferase,
espectively. In both sgl and sfl mutant embryos, Wingless
Wg), fibroblast growth factor (FGF), and Hedgehog (Hh) path-
ays are perturbed, resulting in severe malformations (Lin et
l., 1999; Haerry et al., 1997). In addition, mutational inacti-
ation of the gene, tout-velu (ttv), encoding the Drosophila
omolog of a heparan sulfate copolymerase (Toyoda et al.,
000), disrupts Hedgehog diffusion through embryonic tissues
FIG. 8. GPC3-deficient collecting duct cells demonstrate increase
papilla of E18.5 Gpc31/, SV40-large Tts and Gpc32/, SV40-large Tt
(A) and Gpc32/ (B) kidney papillae were identified by DBA, demon
proliferation in Gpc31/ (C) and Gpc32/ (D) collecting duct cells.
(red-colored) cells were identified in situ with an anti-BrdU antibod
counting four representative microscopic fields in two separate expe
vefold compared to that in Gpc31/ cells (1.1 6 0.3%) (C) (P 5 0.nd results in disruption of Hedgehog signaling (Bellaiche et o
Copyright © 2001 by Academic Press. All rightl., 1998). In the mouse, inactivation of both alleles encoding
eparan sulfate 2-sulfotransferase (HS2ST), an enzyme that
atalyzes the transfer of sulfate to position 2 of the iduronic
cid component of heparan sulfate, causes bilateral renal
genesis and eye and skeletal defects (Bullock et al., 1998).
he observation that ureteric bud branching is defective in the
S2ST null mouse demonstrated a requirement for heparan
ulfate during the initial phase of branching morphogenesis
nd is consistent with prior evidence obtained by pharmaco-
ogic manipulation of embryonic kidney explants with agents
hat interrupt sulfation (Davies et al., 1995).
Heparan sulfate is displayed as a component of geneti-
ally distinct proteoglycans that are associated with the
lasma membrane. Two main families of cell surface pro-
eoglycans have been identified, syndecans and glypicans. A
unctional role for syndecans during renal development has
ot been demonstrated, despite high levels of expression in
he embryonic kidney (Bernfield et al., 1999). Six geneti-
ally distinct glypicans have been identified in mammals
reviewed in Bernfield et al., 1999). The mutant phenotype
l proliferation in vitro. Collecting duct cells were isolated from the
e and passaged in tissue culture. (A, B) Cells isolated from Gpc31/
ing that they are derived from the ureteric bud lineage. (C, D) Cell
s were labeled with BrdU for 4 h prior to fixation. BrdU-positive
e fraction of BrdU-positive cells in each group was determined by






rimef the Gpc3-deficient knock-out mouse (Cano-Gauci et al.,
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(43Glypican-3 Controls Renal Branching MorphogenesisFIG. 9. GPC3 modulates growth factor-mediated control of tubule progenitor formation in vitro. DIC images of CDWT and CDGpc32/ cells
induced to form tubule progenitors in three-dimensional type I collagen gels in the presence of BMP2, BMP7, or KGF. In the absence of
ligand, both cell types formed tubule progenitors. BMP2 totally inhibits tubule formation by CDWT cells but not by CDGpc32/ cells. Low dose
0.25 nM) BMP7 stimulates tubule formation by both CDWT and CDGpc32/ cells. While a 100-fold higher dose (25 nM) of BMP7 inhibits tubule
formation in CDWT cells, only a minor degree of inhibition is observed in CDGpc32/ cell cultures. KGF stimulated tubule formation by CDWTcells with an even greater stimulatory effect observed in CDGpc32/ cells.












ng/ml the stimulatory effect is greater in CDGpc32/ cell cultures (%
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Copyright © 2001 by Academic Press. All right1999; Paine-Saunders et al., 2000) demonstrates that selec-
tive deficiency of a single type of HSPG can perturb embry-
onic development, despite expression of other HSPG in the
same tissue. Further, our analysis of kidney development in
the Gpc32/ mouse shows that such a selective deficiency
can perturb branching morphogenesis via dysregulation of
growth factor signaling and cell proliferation.
The data reported here suggest that GPC3 controls cell
proliferation and growth factor signaling via direct effects
on ureteric bud and collecting duct cells. A previous report
that Gpc3 mRNA is not expressed in ureteric bud deriva-
tives (Pellegrini et al., 1998) raised the possibility that a
soluble extracellular form of GPC3 might act to control
collecting duct cells after enzymatic cleavage of the GPI
linkage and release from metanephric mesenchyme cells.
However, our demonstration that Gpc3 mRNA is expressed
in ureteric bud and collecting duct cells from E13–E18 and
that Gpc3 expression controls growth factor responses in
isolated collecting duct cells provide strong evidence that
GPC3 can act directly to control these responses.
Increased ureteric bud cell proliferation is the earliest
abnormality we detected in the embryonic kidney of
Gpc32/ mice. Evidence in Drosophila and mammalian cell
culture is consistent with a role for GPC3 in controlling cell
proliferation. In the fly, development of the sensory unit
(ommatidium) of the eye is dependent on a highly ordered
pattern of lamina precursor cells in response to signals from
neighboring photoreceptor cells. In dally mutants, cell
divisions in lamina precorsor cells are initially delayed and
then arrested, implicating dally in signaling pathways that
control the cell cycle (Nakato et al., 1995). In mammalian
cells, glypican-1 augments the mitogenic activity of acidic
FGF (aFGF) but inhibits the response to KGF in a manner
dependent on the integrity of its heparan sulfate chains
(Bonneh-Barkay et al., 1997).
The mechanism underlying the spatially restricted high
levels of medullary collecting duct cell apoptosis observed
later during kidney development is less clear. GPC3 has
been shown to regulate apoptosis in a cell-specific manner.
It induces apoptosis in mesothelioma and breast cancer
cells (II14 and MCF7 cell lines, respectively) but not in
fibroblasts or HT-29 colorectal tumor cells (Gonzalez et al.,
1998). While our studies demonstrate that GPC3 deficiency
increases apoptosis in collecting duct cells, it remains
unclear whether this effect is a direct effect of GPC3
deficiency or is secondary to uncontrolled cell proliferation.
The fact that apoptosis occurs much later during develop-
ment suggests that it is a secondary event. It is also
important to note that it has been proposed that GPC3 can
inhibit IGF-II signaling (Pilia et al., 1996). This is based on
stimulation: 50 ng/ml KGF, CDWT vs CDGpc32/ cell cultures, 25.4 6
.7 vs 46.3 6 13.8, P 5 0.02; 100 ng/ml KGF, 29.7 6 6.6 vs 48. 6FIG. 10. Quantification of the effect of Gpc3-deficiency on
growth factor-mediated tubule progenitor formation by CDWT and
DGpc32/ cells. CD cell structures were imaged by DIC 48 h after
nduction of tubule formation. The number of linear tubules
resent in four randomly chosen microscopic fields was quanti-
ated in three independent experiments. (A) BMP2 exerts a
onophasic inhibitory effect on the number of tubules formed by
DWT cells. This inhibitory effect is rescued at doses of BMP2
between 0.15 and 25 nM in cultures of CDGpc32/ cells (maximum
rescue of inhibition at 25 nM BMP2, CDWT vs CDGpc32/ cell cultures:
283.7 6 6.0 vs 236.5 6 8.5, P 5 0.005). (B) BMP7 exerts dose-
dependent and contrasting effects on tubule formation by CDWT
and CDGpc32/ cells. Low dose (0.15 nM BMP7) stimulates CDWT cell
cultures by 21 6 11% and exerts a twofold greater stimulatory
effect on CDGpc32/ cell cultures (46 6 9.1%, P 5 0.03); 0.25 nM
BMP7 exerts a mild inhibitory effect on CDWT cells (16 6 4.5%
nhibition) but stimulates by 40 6 7.7% in CDGpc32/ cell cultures
(CDWT vs CDGpc32/ cell cultures, P 5 0.0005); doses . 0.25 nM
MP7 are increasingly inhibitory in CDWT cultures. This inhibitory
ffect is largely abrogated in CDGpc32/ cell cultures (25 nM BMP7, %
inhibition in CDWT vs CDGpc32/ cell cultures: 72.5 6 6.8 vs 26.2 6
.8, P 5 0.0025). (C) KGF exerts dose-dependent stimulatory effects
n tubule formation in CDWT cultures. At doses of 50 and 10010.4, P 5 0.01).














45Glypican-3 Controls Renal Branching Morphogenesisthe overgrowth of the SGBS patients (Neri et al., 1998) and
on the phenotype of the IGF-II-overexpressing mice, which
also display many of the phenotypic features of SGBS
(Eggenschwiler et al., 1997). However, these mice do not
show any obvious kidney phenotype. Based on this, we
speculate that GPC3 may regulate various growth factors in
a tissue-specific manner. Moreover, it is also possible that
GPC3 modulates the activity of more than one growth
factor in a given cell type. While dally mutants are charac-
terized by abnormal fate of epidermal cells that secrete the
larval cuticle (Tsuda et al., 1999), our studies do not support
role for Gpc3 in controlling collecting duct differentia-
ion. Our data show that markers of “trunk” and “tip”
omain cells are expressed in the Gpc32/ kidney in a
anner identical to that in the Gpc31/ kidney.
Our studies in embryonic kidney explants and collecting
uct cell cultures demonstrate that Gpc3 expression modu-
ates the response to BMP2, BMP7, and KGF. These obser-
ations are consistent with genetic interactions described
n dpp and dally mutants and biochemical interactions in
ammalian cell culture. In Drosophila, dpp antagonizes wg
during patterning of the genitalia. In dally mutants, wg
expression is increased, suggesting that dally is required for
dpp activity during growth factor-mediated organogenesis
(Tsuda et al., 1999). The response of mammalian cells to
acidic FGF and KGF, described above, is modulated by
glypican-1 and may be secondary to the effect of glypican-1
expression on the cell surface binding affinities of aFGF and
KGF (Bonneh-Barkay et al., 1997). The molecular basis for
our observations in ureteric bud and collecting duct cells
remains to be determined. The demonstration that bFGF
forms a molecular complex with cell surface heparan sul-
fate and the FGF cell surface receptor (Rapraeger, 1995)
suggests that GPC3 may physically interact with receptors
that bind BMP2, BMP7, and KGF. The opposite response of
collecting duct cells to GPC3 deficiency, that is, inhibition
of BMP2 activity and enhancement of KGF activity, sug-
gests that the consequences of these interactions may
differ. A second possibility is that GPC3 may function via
independent signaling pathways that physically interact at
the postreceptor level with BMP and KGF signaling inter-
mediates. Alternatively, the GPC3 and growth factor-
signaling pathways may interact indirectly by regulating
competing or complementary gene products. Increasing
evidence regarding the nature of inhibitory and stimulatory
BMP-dependent signaling pathways in collecting duct cells
(Gupta et al., 1999, 2000; Piscione et al., 2001) provides a
basis to determine the nature of GPC3 interactions with
BMP2 and BMP7.
Current knowledge of kidney development suggests a
model in which morphogenesis of the kidney collecting
system results from stimulatory and inhibitory growth
factor-mediated signals that are modulated at the level of
collecting duct cells. Preservation of the balance between
stimulatory and inhibitory signals is critical for normal
development. Our observations in the GPC3-deficient kid-
ney suggest that this molecule modulates inhibitory
Copyright © 2001 by Academic Press. All right(BMP2) and possibly stimulatory (KGF) pathways. Failure to
maintain the balance between stimulatory and inhibitory
signals may underlie dysregulation of the cell cycle and cell
death observed in this unique model of renal dysplasia.
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